|
WO1998035020A2
(en)
|
1997-02-10 |
1998-08-13 |
The Presidents And Fellows Of Harvard College |
Methods for modulating hematopoiesis and vascular growth
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
ES2623711T3
(es)
|
2000-10-13 |
2017-07-12 |
Curis, Inc. |
Antagonistas de hedgehog, procedimientos y usos relacionados con los mismos
|
|
US7708998B2
(en)
|
2000-10-13 |
2010-05-04 |
Curis, Inc. |
Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
|
|
TW200304820A
(en)
*
|
2002-03-25 |
2003-10-16 |
Avanir Pharmaceuticals |
Use of benzimidazole analogs in the treatment of cell proliferation
|
|
AU2003234733B2
(en)
|
2002-04-17 |
2009-01-29 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
DE60322869D1
(de)
*
|
2002-04-22 |
2008-09-25 |
Univ Johns Hopkins |
Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen
|
|
JP2005533119A
(ja)
|
2002-07-17 |
2005-11-04 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物、及び方法
|
|
TWI276631B
(en)
*
|
2002-09-12 |
2007-03-21 |
Avanir Pharmaceuticals |
Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
|
|
JP4726235B2
(ja)
|
2003-04-17 |
2011-07-20 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
癌の処置のためのチェックポイントキナーゼｃｄｓ１（ｃｈｋ２）インヒビターとしての２−フェニル−ベンズイミダゾールおよび２−フェニル−イミダゾ−‘４，５！−ピリジン誘導体
|
|
WO2005030206A1
(en)
*
|
2003-09-24 |
2005-04-07 |
Imclone Systems Incorporated |
Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity
|
|
DK1730280T3
(en)
|
2004-03-26 |
2019-02-04 |
Curis Inc |
RNA interference modulators for hedgehog signaling and applications thereof
|
|
EP1824832B1
(en)
|
2004-06-30 |
2011-04-27 |
Janssen Pharmaceutica NV |
Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents
|
|
DK1789390T3
(da)
|
2004-09-02 |
2012-02-27 |
Genentech Inc |
Pyridyl-inhibitorer af hedgehog-signalering
|
|
EP1807074B1
(en)
|
2004-11-03 |
2013-10-23 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
WO2006094246A2
(en)
*
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
N-arylmethyl benzamide sirtuin modulators
|
|
JP2008535790A
(ja)
*
|
2005-03-03 |
2008-09-04 |
サートリス ファーマシューティカルズ， インコーポレイテッド |
サーチュインモジュレーターであるｎ−フェニルベンズアミド誘導体
|
|
WO2006124780A2
(en)
*
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
|
|
US8093401B2
(en)
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
US8088928B2
(en)
*
|
2005-08-04 |
2012-01-03 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
EP1910385B1
(en)
*
|
2005-08-04 |
2013-07-24 |
Sirtris Pharmaceuticals, Inc. |
Benzothiazoles and thiazolopyridines as sirtuin modulators
|
|
US7855289B2
(en)
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
JP5129149B2
(ja)
|
2005-10-31 |
2013-01-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
癌を処置および診断するための組成物および方法
|
|
US7625759B2
(en)
*
|
2005-12-19 |
2009-12-01 |
Genentech, Inc. |
Method for using BOC/CDO to modulate hedgehog signaling
|
|
WO2008121102A2
(en)
*
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
WO2007126455A2
(en)
|
2006-04-05 |
2007-11-08 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
|
CN103435694A
(zh)
*
|
2006-10-31 |
2013-12-11 |
美国政府卫生与公共服务部 |
Smoothened多肽及使用方法
|
|
EP2121626A1
(en)
*
|
2006-12-15 |
2009-11-25 |
Pfizer Products Inc. |
Benzimidazole derivatives
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
CL2008001821A1
(es)
|
2007-06-20 |
2009-03-13 |
Sirtris Pharmaceuticals Inc |
Compuestos derivados de imidazo[2,1-b]-tiazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, sindrome metabolico, resistencia a la insulina, entre otras.
|
|
TW200916472A
(en)
|
2007-06-20 |
2009-04-16 |
Sirtris Pharmaceuticals Inc |
Sirtuin modulating compounds
|
|
KR101143246B1
(ko)
|
2007-06-29 |
2012-05-18 |
화이자 인코포레이티드 |
벤즈이미다졸 유도체
|
|
JP2011502984A
(ja)
*
|
2007-11-01 |
2011-01-27 |
サートリス ファーマシューティカルズ， インコーポレイテッド |
サーチュインモジュレーターとしてのアミド誘導体
|
|
CA2705138A1
(en)
*
|
2007-11-08 |
2009-05-14 |
Sirtris Pharmaceuticals, Inc. |
Solubilized thiazolopyridines
|
|
AU2008345097A1
(en)
|
2007-12-27 |
2009-07-09 |
Infinity Pharmaceuticals, Inc. |
Methods for stereoselective reduction
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
FR2930552B1
(fr)
*
|
2008-04-24 |
2012-10-12 |
Centre Nat Rech Scient |
N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
|
|
WO2010021381A1
(ja)
*
|
2008-08-22 |
2010-02-25 |
武田薬品工業株式会社 |
縮合複素環誘導体およびその用途
|
|
EP2617414A3
(en)
*
|
2008-10-01 |
2013-11-06 |
Novartis AG |
Smoothened antagonism for the treatment of hedgehog pathway-related disorders
|
|
EP2376502B1
(en)
|
2008-12-19 |
2015-06-17 |
GlaxoSmithKline LLC |
Thiazolopyridine sirtuin modulating compounds
|
|
JP2012529449A
(ja)
*
|
2009-06-11 |
2012-11-22 |
シエナ ビオテク ソシエタ ペル アチオニ |
ヘッジホッグ経路アンタゴニストおよびそれらの治療的応用
|
|
AR077014A1
(es)
*
|
2009-06-19 |
2011-07-27 |
Lilly Co Eli |
Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
|
|
FR2948367A1
(fr)
*
|
2009-07-24 |
2011-01-28 |
Centre Nat Rech Scient |
Derives d'acyl-guanidines modulateurs de la voie de signalisation des proteines hedgehog
|
|
JP6141015B2
(ja)
|
2009-08-05 |
2017-06-07 |
インフィニティ ファーマスーティカルズ、インク． |
シクロパミン類似体の酵素によるアミノ基転移
|
|
PL2470173T3
(pl)
|
2009-08-25 |
2016-11-30 |
|
Leczenie skojarzone nanocząstkowymi kompozycjami taksanu i inhibitorów hedgehog
|
|
CA2799579A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
US9394313B2
(en)
|
2010-09-14 |
2016-07-19 |
Infinity Pharmaceuticals, Inc. |
Transfer hydrogenation of cyclopamine analogs
|
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
複素環化合物及びその使用
|
|
TWI617559B
(zh)
*
|
2010-12-22 |
2018-03-11 |
江蘇恆瑞醫藥股份有限公司 |
２－芳基咪唑并［１，２－ｂ］嗒．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡衍生物
|
|
US9708299B2
(en)
|
2011-01-03 |
2017-07-18 |
Genentech, Inc. |
Hedgehog antagonists having zinc binding moieties
|
|
TWI674262B
(zh)
|
2011-01-10 |
2019-10-11 |
美商英菲尼提製藥股份有限公司 |
製備異喹啉酮之方法及異喹啉酮之固體形式
|
|
WO2013012915A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
|
KR20140075693A
(ko)
|
2011-08-29 |
2014-06-19 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
|
KR102111936B1
(ko)
|
2011-11-25 |
2020-05-18 |
스미또모 가가꾸 가부시끼가이샤 |
망막 조직 및 망막 관련 세포의 제조 방법
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN103570625A
(zh)
*
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
|
EP2914296B2
(en)
|
2012-11-01 |
2021-09-29 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
CA2893133A1
(en)
|
2012-11-29 |
2014-06-05 |
Strasspharma Llc |
Methods of modulating follicle stimulating hormone activity
|
|
US9186361B2
(en)
|
2013-03-15 |
2015-11-17 |
Novartis Ag |
Compounds and compositions for the treatment of parasitic diseases
|
|
US9296754B2
(en)
|
2013-03-15 |
2016-03-29 |
Novartis Ag |
Compounds and compositions for the treatment of parasitic diseases
|
|
US20160024051A1
(en)
|
2013-03-15 |
2016-01-28 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
US9233961B2
(en)
|
2013-03-15 |
2016-01-12 |
Novartis Ag |
Compounds and compositions for the treatment of parasitic diseases
|
|
US9192609B2
(en)
|
2013-04-17 |
2015-11-24 |
Hedgepath Pharmaceuticals, Inc. |
Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors
|
|
SG11201509842SA
(en)
|
2013-05-30 |
2015-12-30 |
Infinity Pharmaceuticals Inc |
Treatment of cancers using pi3 kinase isoform modulators
|
|
WO2015036405A1
(en)
|
2013-09-10 |
2015-03-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing and treating basal cell carcinoma
|
|
MX2021012208A
(es)
|
2013-10-04 |
2023-01-19 |
Infinity Pharmaceuticals Inc |
Compuestos heterocíclicos y usos de los mismos.
|
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2015061204A1
(en)
|
2013-10-21 |
2015-04-30 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2015073691A1
(en)
|
2013-11-14 |
2015-05-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating cancer by activation of bmp signaling
|
|
TWI674263B
(zh)
|
2013-12-19 |
2019-10-11 |
瑞士商諾華公司 |
用於治療寄生蟲疾病之化合物及組合物
|
|
NZ724368A
(en)
|
2014-03-19 |
2023-07-28 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
|
US20150320754A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
|
CN104151250B
(zh)
*
|
2014-07-22 |
2016-08-31 |
大连理工大学 |
一类含苯并咪唑基团的二芳基酰胺类化合物及其合成和应用
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CA2988289C
(en)
|
2015-06-04 |
2023-12-05 |
PellePharm, Inc. |
Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
|
|
US10584118B2
(en)
*
|
2015-06-22 |
2020-03-10 |
Actelion Pharmaceuticals Ltd |
NADPH oxidase 4 inhibitors
|
|
EP4585268A3
(en)
|
2015-09-14 |
2025-10-15 |
Twelve Therapeutics, Inc. |
Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
|
|
US20170231968A1
(en)
|
2016-02-11 |
2017-08-17 |
PellePharm, Inc. |
Method for relief of and treatment of pruritus
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
RU2754507C2
(ru)
|
2016-06-24 |
2021-09-02 |
Инфинити Фармасьютикалз, Инк. |
Комбинированная терапия
|
|
US10767164B2
(en)
|
2017-03-30 |
2020-09-08 |
The Research Foundation For The State University Of New York |
Microenvironments for self-assembly of islet organoids from stem cells differentiation
|
|
CN107056723A
(zh)
*
|
2017-04-21 |
2017-08-18 |
云南大学 |
一种具有抑制血管内皮生长因子受体信号传导的化合物
|
|
JP7323457B2
(ja)
|
2017-05-18 |
2023-08-08 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
肥満細胞疾患の処置のための方法及び医薬組成物
|
|
US12605387B2
(en)
|
2020-07-24 |
2026-04-21 |
Secura Bio, Inc. |
Treatment of cancers using PI3 kinase isoform modulators
|
|
CN112511569B
(zh)
*
|
2021-02-07 |
2021-05-11 |
杭州筋斗腾云科技有限公司 |
网络资源访问请求的处理方法、系统及计算机设备
|
|
CN115477615B
(zh)
*
|
2022-10-17 |
2024-06-18 |
黄山学院 |
N-(3-(苯并咪唑-2-基)苯基)酰胺类化合物及其制备方法和应用
|